Takeda×Otsuka Holdings
Different ways of making money, on the same scale.
Same yardstick
| Metric | TakedaFY ending Mar 2024 | Otsuka HoldingsFY ending Dec 2023 |
|---|---|---|
| Revenue | ¥4.26T | ¥2.02T |
| COGS ratio | — | — |
| Operating margin | — | — |
| Net margin | 3.4% | 6.0% |
| FCF margin | — | — |
Highlighted = best value for that metric
Compare industry percentiles by axis
Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.
- TakedaPrimary industry: Pharmaceuticals
- Otsuka HoldingsPrimary industry: Pharmaceuticals
Revenue growth
- TakedaN/A
- Otsuka HoldingsN/A
- Takeda
Profitability
- TakedaN/A
- Otsuka HoldingsN/A
- Takeda
Cash conversion
- TakedaN/A
- Otsuka HoldingsN/A
- Takeda
Efficiency
- Takeda1.632 peers
- Otsuka Holdings70.332 peers
- Takeda
Financial strength
- TakedaN/A
- Otsuka HoldingsN/A
- Takeda
Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.
Money flows side by side
Chart height is proportional to revenue.
※ Cost of revenue is not disclosed; expenses are combined
※ Operating income is not disclosed; the chart goes straight to pretax income including investment gains
※ Cost of revenue is not disclosed; expenses are combined
※ Operating income is not disclosed; the chart goes straight to pretax income including investment gains
Analyze this page with AI
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.